CVE:COV Covalon Technologies (COV) Stock Price, News & Analysis C$2.35 +0.07 (+3.07%) As of 05/2/2025 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsHeadlinesBuy This Stock About Covalon Technologies Stock (CVE:COV) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Covalon Technologies alerts:Sign Up Key Stats Today's RangeC$2.28▼C$2.3550-Day RangeC$2.18▼C$2.8352-Week RangeC$1.00▼C$4.30Volume21,915 shsAverage Volume35,539 shsMarket CapitalizationC$64.39 millionP/E Ratio26.97Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewCovalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity. It also offers medical coating platform, a process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device. In addition, the company provides wound care dressings; surgical and peri-operative; and infection management products. It offers its products under the Covalon brand name through third-party distribution networks and company's direct sales force. The company serves hospitals, wound care centers, burn centers, extended/alternate care and acute care facilities, home health care agencies, and physicians' offices. Covalon Technologies Ltd. is headquartered in Mississauga, Canada.Read More… Receive COV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Covalon Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address COV Stock News HeadlinesCovalon Technologies to benefit from Trump tariffsApril 3, 2025 | msn.comCovalon Technologies Ltd.March 14, 2025 | wsj.comWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."May 5, 2025 | Brownstone Research (Ad)Covalon Technologies Ltd. (CVALF) Q1 2025 Earnings Call TranscriptFebruary 23, 2025 | seekingalpha.comCovalon Technologies First Quarter 2025 Earnings: EPS: CA$0.04 (vs CA$0.035 loss in 1Q 2024)February 22, 2025 | uk.finance.yahoo.comCovalon Technologies earns fourth-straight quarterly profitFebruary 21, 2025 | msn.comCovalon Technologies Releases Statement on United States – Canada Trade DisputeFebruary 3, 2025 | uk.finance.yahoo.comCovalon Technologies Ltd.'s (CVE:COV) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?January 8, 2025 | finance.yahoo.comSee More Headlines COV Stock Analysis - Frequently Asked Questions How have COV shares performed this year? Covalon Technologies' stock was trading at C$3.25 at the start of the year. Since then, COV stock has decreased by 27.7% and is now trading at C$2.35. View the best growth stocks for 2025 here. How do I buy shares of Covalon Technologies? Shares of COV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Covalon Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Covalon Technologies investors own include NIO (NIO), Reliq Health Technologies (RHT), Facedrive (FDVRF), Meta Platforms (META), NVIDIA (NVDA), Ackroo (AKR) and BeWhere (BEW). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:COV CIKN/A Webwww.covalon.com Phone+1-905-5688400FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)C$0.09 Trailing P/E Ratio26.97 Forward P/E Ratio7.83 P/E GrowthN/ANet IncomeC$2.39 million Net Margins8.57% Pretax MarginN/A Return on Equity12.33% Return on Assets-3.25% Debt Debt-to-Equity Ratio3.28 Current Ratio7.27 Quick Ratio6.45 Sales & Book Value Annual SalesC$27.87 million Price / Sales2.31 Cash FlowC$0.55 per share Price / Cash Flow4.28 Book ValueC$0.90 per share Price / Book2.62Miscellaneous Outstanding Shares27,398,100Free FloatN/AMarket CapC$64.39 million OptionableNot Optionable Beta0.64 The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (CVE:COV) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Covalon Technologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Covalon Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.